We had the pleasure of speaking live with Armin Khayatian at the Psychedelic Therapeutics & Drug Development Conference about the vision behind Lionheart Ventures. We discussed how Lionheart Ventures approaches transformative technologies, and Armin shared his perspective on the evolution of the psychedelic sector, including the market response to Compass Pathways’ latest results. This conversation was recorded as part of Cascades Analytics’ on-site conference coverage, in partnership with Arrowhead SciTech Conferences & Events.